BOSTON (TheStreet) -- The American Society of Clinical Oncology (ASCO) posted thousands of cancer drug research abstracts to its web site Thursday night, in advance of its closely watched annual meeting.
The ASCO annual meeting runs June 4-8 and brings together cancer drug researchers from all over the world to discuss and present new clinical data aimed at treating -- and maybe one day curing -- cancer.
The ASCO annual meeting also attracts investors in almost equal numbers because treating cancer is big business. Wall Street pays close attention because the ASCO meeting moves biotech and drug stocks, often well before the ASCO confab even gets started.
Wall Street's focus on the ASCO annual meeting kicked into another gear Thursday night with the release of the research abstracts. Previously, I assembled a list of biotech and drug stocks that will be presenting new clinical data at this year's ASCO meeting. I've now updated this list with information and data taken from the newly released research abstracts.> > Bull or Bear? Vote in Our Poll Flip through the list of ASCO stocks on the following pages:
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV